Autopsy report · NCT02102022
Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma
Cause of deathNo reason given
Life of this trial
- Registered 8 months before it started.
- Ran for about 5 years 3 months before it stopped.
- 140 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Polaris Group
- Sponsor type
- Industry
- Conditions
- Advanced Gastrointestinal (GI) Malignancies; Hepatocellular Carcinoma; Gastric Cancer; Colorectal Cancer
- Interventions
- ADI-PEG 20 plus modified FOLFOX6
- Participants
- 140
- Sites
- 35
- Countries
- China, Italy, South Korea, Taiwan, United Kingdom, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.